A Cardiff-based innovative marine biotech firm which extracts collagen from jellyfish, has closed an £8.7m Series A equity investment round. Jellagen has secured investment from the Cardiff Capital Region (CCR), the Development Bank of Wales, and the Thai Union Group PCL.
The Development Bank of Wales invested £1.2m in equity, while the Cardiff City Deal backed the investment round with £2m with the aim of building medical device expertise in south Wales and growing the sector in the region.
Read more: Plans for over 400 new homes to be built at old quarry site